Wim E. Hennink
Impact in
- Molecular Medicine top 0.01%
- Hydrogels: synthesis, properties, applications
- Biomaterials top 0.01%
- Nanoparticle-Based Drug Delivery
Papers in
- Biomaterials 265
- Nanoparticle-Based Drug Delivery 160
- biodegradable polymer synthesis and properties 53
-
- RNA Interference and Gene Delivery 150
- Advanced biosensing and bioanalysis techniques 68
- Co-authors
- Cornelus F. van Nostrum (168 shared papers)Gert Storm (100 shared papers)Tina Vermonden (94 shared papers)Twan Lammers (65 shared papers)Daan J.A. Crommelin (77 shared papers)Stefaan C. De Smedt (36 shared papers)Fabian Kießling (30 shared papers)Enrico Mastrobattista (54 shared papers)
- Journals
- Journal of Controlled Release (118 papers)International Journal of Pharmaceutics (45 papers)Biomacromolecules (40 papers)Pharmaceutical Research (38 papers)Biomaterials (35 papers)
- Partner nations
- NetherlandsGermanyBelgium
In The Last Decade
Wim E. Hennink
632 papers receiving 55.4k citations
Wim E. Hennink's Hit Papers
Peers
Comparison fields: 5 of 189
- Molecular Medicine 10.0k
- Biomaterials 23.4k
- Pharmaceutical Science 6.9k
- Surfaces, Coatings and Films 3.9k
- Biomedical Engineering 18.4k
Countries citing papers authored by Wim E. Hennink
This map shows the geographic impact of Wim E. Hennink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wim E. Hennink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wim E. Hennink more than expected).
Fields of papers citing papers by Wim E. Hennink
This network shows the impact of papers produced by Wim E. Hennink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wim E. Hennink. The network helps show where Wim E. Hennink may publish in the future.
Co-authors
The 25 scholars most cited alongside Wim E. Hennink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 634 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Novel crosslinking methods to design hydrogels Hit paper breakdown → | 2002 | 1740 |
| 2 | 25th Anniversary Article: Engineering Hydrogels for Biofabrication Hit paper breakdown → | 2013 | 1633 |
| 3 | Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress Hit paper breakdown → | 2011 | 1151 |
| 4 | Reduction-sensitive polymers and bioconjugates for biomedical applications Hit paper breakdown → | 2009 | 1034 |
| 5 | Novel crosslinking methods to design hydrogels Hit paper breakdown → | 2012 | 1028 |
| 6 | Hydrogels for Protein Delivery Hit paper breakdown → | 2012 | 988 |
| 7 | Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release Hit paper breakdown → | 2010 | 826 |
| 8 | Hydrogels in a historical perspective: From simple networks to smart materials Hit paper breakdown → | 2014 | 821 |
| 9 | Cationic Polymer Based Gene Delivery Systems Hit paper breakdown → | 2000 | 801 |
| 10 | Curcumin nanoformulations: A review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment Hit paper breakdown → | 2014 | 755 |
| 11 | Theranostic Nanomedicine Hit paper breakdown → | 2011 | 749 |
| 12 | Cyclodextrin-Based Polymeric Materials: Synthesis, Properties, and Pharmaceutical/Biomedical Applications Hit paper breakdown → | 2009 | 551 |
| 13 | In situ gelling hydrogels for pharmaceutical and biomedical applications Hit paper breakdown → | 2008 | 546 |
| 14 | Chitosan-based delivery systems for protein therapeutics and antigens Hit paper breakdown → | 2009 | 544 |
| 15 | Identification of Formaldehyde-induced Modifications in Proteins Hit paper breakdown → | 2004 | 511 |
| 16 | 2007 | 493 | |
| 17 | Interpenetrating Polymer Networks polysaccharide hydrogels for drug delivery and tissue engineering Hit paper breakdown → | 2013 | 473 |
| 18 | 2008 | 467 | |
| 19 | Core-crosslinked polymeric micelles: Principles, preparation, biomedical applications and clinical translation Hit paper breakdown → | 2015 | 447 |
| 20 | 2007 | 430 |
About Wim E. Hennink
Wim E. Hennink is a scholar working on Biomaterials, Molecular Biology, Biomedical Engineering, Molecular Medicine and Organic Chemistry, having authored 634 papers that have together received 56.6k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (160 papers), RNA Interference and Gene Delivery (150 papers), Hydrogels: synthesis, properties, applications (112 papers), Advanced Drug Delivery Systems (88 papers), Advanced Polymer Synthesis and Characterization (73 papers), Advanced biosensing and bioanalysis techniques (68 papers), biodegradable polymer synthesis and properties (53 papers) and Nanoplatforms for cancer theranostics (53 papers). The work is most often cited by research in Molecular Medicine (10.0k citations), Biomaterials (23.4k citations), Pharmaceutical Science (6.9k citations), Surfaces, Coatings and Films (3.9k citations) and Biomedical Engineering (18.4k citations). Wim E. Hennink has collaborated with scholars based in Netherlands, Germany and Belgium. Frequent co-authors include Cornelus F. van Nostrum, Gert Storm, Tina Vermonden, Twan Lammers, Daan J.A. Crommelin, Stefaan C. De Smedt, Fabian Kießling, Enrico Mastrobattista, Raymond M. Schiffelers and Mies J. van Steenbergen. Their work appears in journals such as Journal of Controlled Release, International Journal of Pharmaceutics, Biomacromolecules, Pharmaceutical Research and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.